Page results
-
The Edward Showler Foundation and UCL have forged a philanthropic partnership that will support pioneering research into clear cell sarcoma (CCS) – a rare type of soft tissue cancer with few…
-
The trial results are good news for non-small cell lung cancer patients who are not eligible for standard of care platinum-based chemotherapy.
-
Spectacular rainbow floral and balloon installations by Early Hours London and Bubblegum Balloons thank the public for their support during the pandemic.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
It is with great pleasure and excitement that we share with you news of an excellent new resource that can be used across the UK for people living with Sickle Cell Disorder.
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
The first UK participant in a portion of a study looking at a new investigational medication for Covid-19 has received their initial dose of the drug at UCLH.
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
Eleven MSF staff are now providing nursing and logistics support at the London COVID CARE Centre, in partnership with the UCLH Find & Treat team.
